[Preclinical evaluation of alboverticillin, triculamine, and o-carbamyl-d-serine as a new antituberculous antibiotic].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D006168:Guinea Pigs; D051379:Mice; D009161:Mycobacterium / Q000187:drug effects*; D014376:Tuberculosis / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents